Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04923893 |
|---|---|
| Brief Title: | A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy (CARTITUDE-5) |
| First Submitted : | June 10, 2021 |
| First Submitted that Met QC Criteria : | June 10, 2021 |
| First Posted : | June 11, 2021 |
| Last Update Submitted that Met QC Criteria : | April 23, 2024 |
| Last Update Posted : | April 24, 2024 |